Objectives To assess patient characteristics, treatment patterns, and patient-reported
outcomes (PROs) associated with authorized generics (AGs) and independent generics …

Don’t stop the statin! Page 1 ....................................................................................................................
Don’t stop the statin! Christopher P. Cannon* Cardiovascular Innovation, Cardiovascular Division …

This review of cardiovascular health risk assessment and therapeutic approach to
prevention of atherosclerotic cardiovascular disease (ASCVD) is intended to provide an …

Sudden cardiac death (SCD) is defined as a sudden natural death presumed to beof cardiac
cause, heralded by abrupt loss of consciousness in the presence of witness, or in the …

Les déclarations d'intérêt des auteurs, tous salariés de la Caisse nationale de l'assurance
maladie (Cnam), de l'Agence nationale de sécurité du médicament et des produits de santé …

Background The American Heart Association and American College of Cardiology
guidelines defined patient‐management groups that would benefit from lowering of low …

LDL (low density lipoprotein)-Cholesterin-senkende Therapien stellen einen etablierten
Therapiebaustein in der kardiovaskulären Prävention dar. Für jüngere Patienten existiert …

We found the multicenter registry study by Torres-Peña et al.[1] very interesting and well
organized. The authors were able to show that hospitalized COVID-19 patients who …

Older adults who discontinue primary prevention statin therapy may experience an excess of
one major adverse cardiovascular event for every 112 persons (SOR: B, large cohort study) …

A total of 829 physicians and advanced practice providers within a large, mostly primary
care network were surveyed about their personal use of statins and their attitudes toward …